|1.||Shenoy, Erica S: 3 articles (09/2015 - 06/2014)|
|2.||Blumenthal, Kimberly G: 2 articles (09/2015 - 06/2014)|
|3.||Youngster, Ilan: 2 articles (08/2014 - 06/2014)|
|4.||Nelson, Sandra B: 2 articles (08/2014 - 06/2014)|
|5.||Sakoulas, George: 2 articles (02/2014 - 01/2011)|
|6.||Stevens, Dennis L: 2 articles (01/2007 - 01/2006)|
|7.||Climo, Michael W: 2 articles (09/2006 - 06/2002)|
|8.||Rhodes, Nathaniel J: 1 article (09/2015)|
|9.||Lee, Benjamin J: 1 article (09/2015)|
|10.||Scheetz, Marc H: 1 article (09/2015)|
04/01/1989 - "In vivo, nafcillin was equally effective against experimental aortic valve endocarditis in rabbits, regardless of whether they were infected by a fully susceptible or a low-level-resistant strain. "
04/01/1989 - "Nafcillin was ineffective against endocarditis caused by a truly methicillin-resistant strain, and resistance emerged on therapy. "
06/01/1984 - "The validity of laboratory tests that define bactericidal activity to predict antimicrobial efficacy was studied in rabbits with endocarditis due to Staphylococcus aureus, both nafcillin-nontolerant (NT) and nafcillin-tolerant (T). "
01/22/1982 - "Nafcillin-tolerant Staphylococcus epidermidis endocarditis."
09/01/1978 - "Nafcillin therapy for Staphylococcus aureus endocarditis."
12/01/1978 - "Results from this study indicate that nafcillin is a safe and effective antibiotic for the treatment of infections due to susceptible bacteria in the dosage tested."
09/01/1964 - "CLINICAL STUDY OF NAFCILLIN FOR STAPHYLOCOCCAL SOFT TISSUE AND MUCOUS MEMBRANE INFECTIONS IN A GENERAL PRACTICE."
02/01/2014 - "Nafcillin reduces virulence of MRSA in a murine subcutaneous infection model."
02/01/2014 - "Finally, nafcillin pretreatment ex vivo reduced MRSA virulence in a murine subcutaneous infection model. "
08/01/2006 - "He recovered after 6 weeks of nafcillin therapy without any residual infection. "
01/01/2015 - "He was diagnosed with sternoclavicular osteomyelitis and placed on a 6-week course of intravenous Nafcillin. "
01/01/2010 - "To our knowledge, this is the first report describing the successful use of the continuous infusion of nafcillin to treat an infant who had sternal osteomyelitis after cardiac surgery."
01/01/2010 - "We report the use of the continuous infusion of nafcillin for the treatment of an infant who had methicillinsusceptible Staphylococcus aureus sternal osteomyelitis not responsive to traditional nafcillin dosing. "
01/01/2010 - "Continuous infusion of nafcillin for sternal osteomyelitis in an infant after cardiac surgery."
03/01/1984 - "Osteomyelitis: oral nafcillin therapy not useful."
02/01/2014 - "The use of nafcillin as adjunctive therapy in MRSA bacteremia merits further study and should be considered in cases refractory to standard therapy. "
02/01/2014 - "Nafcillin has been used as adjunctive therapy to clear persistent MRSA bacteremia. "
01/01/2006 - "In clinical practice, however, nafcillin remained the treatment of choice for staphylococcal bacteremia, largely because it had failure rates of only 4%. "
07/01/1986 - "A randomized cooperative study of therapy for Staphylococcus aureus bacteremia was conducted in which nafcillin was given for four or six weeks to patients with clinical endocarditis and for two or four weeks to those without evidence of endocarditis. "
03/01/1976 - "Serial serum and cerebrospinal fluid nafcillin concentrations were determined in a patient successfully treated with nafcillin (200 mg/kg per day) for Staphylococcus aureus bacteremia and meningitis. "
|5.||Drug Toxicity (Drug Safety)
05/15/1997 - "Adverse drug reactions in home care patients receiving nafcillin or oxacillin."
06/01/1978 - "Methicillin and nafcillin are equally effective in treating S aureus infections, but methicillin was significantly and more frequently associated with adverse drug reaction that was nafcillin."
01/01/2002 - "This study compared adverse drug reactions (ADRs) to oxacillin with those to nafcillin and other antibiotics. "
|9.||Anti-Bacterial Agents (Antibiotics)
|1.||Renal Dialysis (Hemodialysis)
|4.||Skin Transplantation (Skin Grafting)